The Series B proceeds are primarily dedicated to constructing an in-house specialised AI imaging laboratory housing Qureight’s proprietary 3D chest imaging foundation model. This technological development marks a shift from task-specific narrow AI models toward generalised spatial representations, drastically reducing both the data volume and the development time required to deploy predictive models in new therapeutic indications. Consequently, Qureight is extending its estab